NueCell Bio
San Diego, CA, United States nuecellbio.com From their website, Nov 2026
- GMP
- ISO 9001
Work here? Claim this listing
About
NueCell Bio is a California-based cell therapy development company that works with academic, biotechnology, and pharmaceutical clients to advance cell therapies from early research into clinical development and GMP manufacturing. It focuses on bridging discovery science and manufacturing for autologous and allogeneic cell therapy programs at its San Diego facility.
Services
Program Design & Feasibility
Evaluates equipment, raw materials, analytics, and workflow fit up front through gap assessments, feasibility studies, and QbD-driven program scoping.
Cell Engineering
Provides cell reprogramming, gene editing, and characterization services, including footprint-free reprogramming and multiple genetic modification systems.
Process Design & Development
Develops and optimizes cell therapy unit operations, scale-up and scale-down models, automation, and transfer-ready processes.
Analytical Design, Development & Testing
Develops and qualifies in-house assays for cell characterization, potency, safety, sterility, stability, and comparability.
Cell Banking
Creates research cell banks, iPSC-specific banks, and analytical control banks with characterization, traceability, storage, and documentation.
Quality, Supply Chain & Logistics
Manages quality systems, SOPs, deviation and CAPA, change control, supplier qualification, raw material sourcing, and cold-chain logistics.
Technology Transfer
Prepares locked process and analytical transfer packages, draft batch records, risk assessments, and confirmation runs for GMP handoff.
- Turnaround
- Within two business days
- 2 days median response time for new program inquiries
- Within 2 business days
- What to send
- Company/Organization Name
- Program Stage
- Discovery
- IND-enabling
- Pre-clinical
- Tell Us About Your Program
Capabilities
- Assays and studies
- Cell therapy
- CRISPR
- Stability studies
- Process development
- Flow cytometry
- qPCR
18 more
- NGS
- STR profiling
- Karyotype analysis
- Copy number analysis
- Zygosity confirmation
- Cytotoxicity assays
- Cytokine secretion assays
- Target-specific killing assays
- Co-culture readouts
- ddPCR
- Sterility testing
- Mycoplasma testing
- Endotoxin testing
- Luminex
- Immunocytochemistry
- Amplicon NGS
- On/off-target NGS
- STR identity testing
- Scale and capacity
- 26,300-square-foot facility
- Mid- to full-scale confirmation runs
- 26,300 ft2 facility
- Therapeutic areas
- Cancer
- Immune disorders
- Tissue damage
Instruments and platforms
- Luminex
Modalities and species
- Modalities
- Cell therapy
- Gene editing
- Species and models
- T cells
- NK cells
- Myeloid cells
- HSC
- PSC
- MSC
- Fibroblast starting material
- Blood-derived starting material
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: cGMP-ready (raw materials and transfer-ready processes)
ISO 9001Self-reported
Scope: operated in compliance since launch; annual recertification since launch
Industries served
- Biotechnology
- Pharmaceutical companies
- Academic institutions
- Cell therapy
- Biotech
Details
- Type
- CRO
- Address
- 10421 Wateridge Circle Suites 150 & 250 San Diego, CA 92121
- Serves
- United States, Europe, Japan, South Korea, California